
|Articles|September 1, 2003
Foreign Filler on its Way to U.S.A.
San Francisco - For patients who want to smooth out wrinkles and facial lines but who cannot tolerate collagen injections, alternative fillers already in use in other countries are at the cusp of FDA approval. More people than ever are interested in pursuing such anti-aging measures, as worldwide facial aesthetic product sales in the first quarter of 2003 rose to $17 million, an increase of 8 percent over the first quarter of 2002.
Advertisement
Newsletter
Like what you’re reading? Subscribe to Dermatology Times for weekly updates on therapies, innovations, and real-world practice tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Dermatology Times
1
Phase 3 Data Position Zasocitinib as a Potential New Oral Option for Psoriasis
2
Highlighting Major Breakthroughs for Atopic Dermatitis and Psoriasis in 2025
3
First-in-Class Topical GT20029 Demonstrates Promising Phase 2 Efficacy and Tolerability for AGA
4
Topicals Demonstrate Targeted Control Across 3 Distinct Atopic Dermatitis Cases
5

















